Table 3.
Comparison of survey results between providers and consumers (relative risks [RR] in reference to providers:consumers).
| Survey items | Provider, n (%) |
Consumer, n (%) |
RR | RR 95% CI | P valued | |
| Q1. Technology a (choose one) | <.001 | |||||
|
|
Like technology, prefer professional diagnosis | 819 (58.25) | 490 (44.46) | 1.3 | 1.2-1.4 |
|
|
|
Like technology for diagnosis | 194 (13.80) | 437 (39.66) | 0.70 | 0.66-0.74 |
|
|
|
Uneasy using technology | 393 (27.95) | 175 (15.88) | 1.2 | 1.1-1.2 |
|
| Q2. Support genetic testing b (% No) | ||||||
|
|
Having a baby | 172 (12.23) | 296 (26.86) | 0.83 | 0.80-0.87 | <.001 |
|
|
Diagnose problems in fetus | 117 (8.32) | 207 (18.78) | 0.89 | 0.86-0.92 | <.001 |
|
|
Treat disease | 39 (2.77) | 70 (6.35) | 0.96 | 0.95-0.98 | <.001 |
|
|
Disease prevention | 80 (5.69) | 73 (6.62) | 0.99 | 0.97-1.0 | .66 |
|
|
Treat infections | 228 (16.07) | 122 (10.16) | 1.1 | 1.0-1.1 | <.001 |
|
|
Identify drug side effects | 172 (12.23) | 145 (13.16) | 0.99 | 0.96-1.0 | .81 |
|
|
Prolong lifespan | 394 (28.02) | 277 (25.14) | 1.0 | 0.99-1.1 | .05 |
|
|
Identify cause of death | 209 (14.86) | 172 (15.61) | 0.99 | 0.96-1.0 | .56 |
| Q3. Blood tests using smartphoneb (% No) | 530 (37.70) | 399(36.21) | 1.0 | 0.96-1.1 | .029 | |
| Q4. Send/accept information via smartphone b (% No) | ||||||
|
|
Skin problem | 737 (52.42) | 412 (37.39) | 1.3 | 1.2-1.4 | <.001 |
|
|
Heart rate/rhythm | 554 (39.40) | 379 (34.39) | 1.1 | 1.0-1.1 | <.001 |
|
|
Eye exam | 983 (69.91) | 565 (51.27) | 1.6 | 1.5-1.8 | <.001 |
|
|
Ear exam | 962 (68.42) | 509 (46.19) | 1.7 | 1.6-1.9 | <.001 |
| Q5. Hesitant due to privacy concernsb (% true) | 492 (34.99) | 466 (42.29) | .89 | .83-.95 | .033 | |
| Q6. Ownership of medical record a (choose one) | <.001 | |||||
|
|
Provider owns records | 613 (43.60) | 258 (23.41) | 1.4 | 1.3-1.4 |
|
|
|
Patient owns records | 431 (30.65) | 594 (54.90) | 0.66 | 0.62-0.71 |
|
|
|
Don’t know who owns records | 362 (25.75) | 250 (22.69) | 1.0 | 0.99-1.1 |
|
| Q7. Access to med records b (% I/Patient have/has a right to see) | ||||||
|
|
Patient has right to see all test results | 1339 (95.23) | 1060 (96.19) | 0.80 | 0.55-1.2 | .54 |
|
|
Patient has right to see all doctors’ notes | 884 (62.87) | 984 (89.29) | 0.29 | 0.24-0.35 | <.001 |
| Q8. Access to EHR information b (% No) | ||||||
|
|
Could lead to feeling anxious about results | 136 (9.67) | 724 (65.70) | 0.38 | 0.35-0.41 | <.001 |
|
|
Could lead to better management of my health | 375 (26.67) | 80 (7.26) | 1.3 | 1.2-1.3 | <.001 |
|
|
Could lead to requesting unnecessary medical evaluations | 257 (18.28) | 831 (75.41) | 0.30 | 0.28-0.33 | <.001 |
| Q9. Access to lab tests a (choose one) | <.001 | |||||
|
|
Provider should review | 1096 (77.95) | 641 (58.17) | 1.9 | 1.7-2.1 |
|
|
|
Patients should have access | 182 (12.94) | 377 (34.21) | 0.76 | 0.72-0.79 |
|
|
|
Doctors review results that may cause concern | 128 (9.10) | 84 (7.62) | 1.0 | 0.99-1.0 |
|
| Q10. Cost medical procedureb (% No) | 718 (51.07) | 549 (49.82) | 1.0 | 0.94-1.1 | .34 | |
| Q11. Right to know full cost of procedureb (% agree) | 1364 (97.01) | 1057 (95.92) | 1.4 | 0.90-2.1 | .13 | |
| Q12. Prices charged by different providersb (% No) | 133 (9.46) | 71 (6.44) | 1.0 | 1.0-1.1 | .40 | |
| Q13. Annual physicals a (choose one) | .039 | |||||
|
|
Annual exam is necessary | 837 (59.53) | 683 (61.98) | 0.94 | 0.85-1.0 |
|
|
|
Alternatives for monitoring health | 456 (32.43) | 340 (30.85) | 1.0 | 0.97-1.1 |
|
|
|
Annual physical unnecessary | 113 (9.46) | 79 (7.17) | 1.0 | 0.99-1.0 |
|
| Q14. Concern about radiation exposurec, mean (SD) | 4.28 (1.7) | 3.53 (2.0) |
|
|
<.001 | |
| Q15. Feelings about new technology b (choose one) | <.001 | |||||
|
|
Must be mastered | 806 (57.33) | 405 (36.75) | 1.5 | 1.4-1.6 |
|
|
|
It is exciting | 548 (38.98) | 487 (44.19) | 0.91 | 0.86-0.98 |
|
|
|
It is beyond me | 37 (2.63) | 166 (15.06) | 0.87 | 0.85-0.90 |
|
|
|
It scares me | 15 (1.07) | 44 (3.99) | 0.97 | 0.96-0.98 |
|
aMultinomial probit regression.
bProbit regression.
cLinear regression.
dAge and gender modeled as covariates.